[Practical use of anti-HB immunoglobulins].
Viral hepatitis B remains a significant problem among iatrogenic infections. The development of transplantology met a barrier in the form of active hepatitis B. Wide but still inadequate prophylaxis against viral hepatitis B and the necessity of protection of patients after organ transplantation against secondary HBV infection require establishing indications for specific, passive immunotherapy.
Lapiński
T W
TW
Klinika Obserwacyjno-Zakaźna, Akademii Medycznej w Białymstoku. doctors@friko.onet.pl
Kalinowska
A
A
Prokopowicz
D
D
D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D016031:Liver Transplantation / Q000276:immunology; D055502:Secondary Prevention
D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin